Contact
searchSearch
HMP Global

May 2018 - FRMC

Column

Viewpoint
Using Predictive Analytics to Address Social Determinants of Health
05/31/2018
Virginia Gurley, MD, MPH
Recognizing the importance of social determinants of health, many health plans are expanding their care management capabilities to help members overcome nonmedical barriers.
Recognizing the importance of social determinants of health, many health plans are expanding their care management capabilities to help members overcome nonmedical barriers.
Recognizing the importance of...
05/31/2018
First Report Managed Care

Department

Managed Care Q&A
How URAC Specialty Pharmacy Accreditation Improves Pharmacy Outcomes
05/31/2018
David Costill
An interview with Heather Bonome, PharmD, Director of Pharmacy at URAC.
An interview with Heather Bonome, PharmD, Director of Pharmacy at URAC.
An interview with Heather...
05/31/2018
First Report Managed Care
Conference Insider
Eptinezumab Reduced Migraine Activity, Utilization of Triptan/Ergotamine
05/31/2018
Two presentations at the 2018 American Academy of Neurology Annual Meeting highlighted the benefits of the intravenous migraine treatment eptinezumab.
Two presentations at the 2018 American Academy of Neurology Annual Meeting highlighted the benefits of the intravenous migraine treatment eptinezumab.
Two presentations at the 2018...
05/31/2018
First Report Managed Care
Conference Insider
Aimovig Safe, Effective at Reducing Monthly Migraine Days
05/31/2018
A recent study presented at the 2018 American Academy of Neurology Annual Meeting found that Aimovig (erenumab; Novartis/Amgen) significantly reduced monthly migraine days among patients who failed two to four prior preventive migraine...
A recent study presented at the 2018 American Academy of Neurology Annual Meeting found that Aimovig (erenumab; Novartis/Amgen) significantly reduced monthly migraine days among patients who failed two to four prior preventive migraine...
A recent study presented at the...
05/31/2018
First Report Managed Care
Conference Insider
Entresto Reduces Health Care Costs in Heart Failure Patients
05/31/2018
Data presented at the AMCP 2018 Annual Meeting demonstrated that Entresto (sacubitril/valsartan; Novartis) reduced all-cause hospitalizations and health care costs in patients with heart failure with reduced ejection fraction.
Data presented at the AMCP 2018 Annual Meeting demonstrated that Entresto (sacubitril/valsartan; Novartis) reduced all-cause hospitalizations and health care costs in patients with heart failure with reduced ejection fraction.
Data presented at the AMCP 2018...
05/31/2018
First Report Managed Care
Conference Insider
Study Examines Costs of Oral vs Injectable Immunotherapies
05/31/2018
A study at the AMCP 2018 Annual Meeting compared health care utilization, medication switching, and costs among patients taking oral immunotherapies and injectable immunotherapies.
A study at the AMCP 2018 Annual Meeting compared health care utilization, medication switching, and costs among patients taking oral immunotherapies and injectable immunotherapies.
A study at the AMCP 2018 Annual...
05/31/2018
First Report Managed Care
Conference Insider
New Shingles Vaccine Cost-Effective, Cost-Saving Compared With Zostavax
05/31/2018
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP...
05/31/2018
First Report Managed Care
Conference Insider
Patients Taking Haegarda Used Less On-Demand Therapy, Reduce Plan Spending
05/31/2018
A poster presented at the AMCP 2018 Annual Meeting showed that patients with hereditary angioedema who received Haegarda (C1 esterase inhibitor subcutaneous; CSL Behring) took less on-demand therapy during prophylactic treatment.
A poster presented at the AMCP 2018 Annual Meeting showed that patients with hereditary angioedema who received Haegarda (C1 esterase inhibitor subcutaneous; CSL Behring) took less on-demand therapy during prophylactic treatment.
A poster presented at the AMCP...
05/31/2018
First Report Managed Care
Conference Insider
Diabetes Patients With Multiple Daily Injections Have Low Persistence, High Medical Costs
05/31/2018
An award-winning poster at the AMCP 2018 Annual Meeting found that type 2 diabetes patients who need multiple daily injections of basal-bosul insulin have low 1-year persistence and higher medial costs
An award-winning poster at the AMCP 2018 Annual Meeting found that type 2 diabetes patients who need multiple daily injections of basal-bosul insulin have low 1-year persistence and higher medial costs
An award-winning poster at the...
05/31/2018
First Report Managed Care
Conference Insider
Pharma Trends in 2018: Generic Drugs in “Race to the Bottom,” Biosimilars Fail to Launch, Market Access Faces Challenges
05/31/2018
During his presentation at the AMCP 2018 Annual Meeting, “2017-2018 Pharmaceutical Marketplace Trends,” Douglas Long, BS, MBA, vice president of Industry Relations at IQVIA, outlined the market trends impacting the pharmaceutical...
During his presentation at the AMCP 2018 Annual Meeting, “2017-2018 Pharmaceutical Marketplace Trends,” Douglas Long, BS, MBA, vice president of Industry Relations at IQVIA, outlined the market trends impacting the pharmaceutical...
During his presentation at the...
05/31/2018
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Elizabeth Brem University of California Irvine
Videos
Analyzing Patient Selection and the Utility of CNS Prophylaxis for Patients With DLBCL
04/20/2023
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great...
04/20/2023
Oncology
News
Thousands Face Medicaid Coverage Disruptions in South Dakota and North Carolina
05/18/2023
Arielle Zionts
Now that the public health emergency has expired, individuals may lose coverage but then requalify several months later in states which have recently approved Medicaid expansion.
Now that the public health emergency has expired, individuals may lose coverage but then requalify several months later in states which have recently approved Medicaid expansion.
Now that the public health...
05/18/2023
First Report Managed Care
News
Digital Therapeutics "Viable Solution" for Mental Health Needs
06/07/2023
Jolynn Tumolo
“The participants were willing to utilize digital therapeutics if available, and even preferred this type of support compared to actually visiting a clinic,” researchers wrote.
“The participants were willing to utilize digital therapeutics if available, and even preferred this type of support compared to actually visiting a clinic,” researchers wrote.
“The participants were willing...
06/07/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
Amanda Balbi
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
First Report Managed Care
Stock image of a doctor holding a phone
Commentary
Prescription Digital Therapeutics: Ongoing Efforts to Expand Awareness, Integrate Into Clinical Practice
07/28/2023
Yvette C. Terrie, BS Pharm, RPh
Yvette Terrie shares digital therapeutic updates regarding FDA approvals, recent and upcoming clinical trials, and current industry regulations.
Yvette Terrie shares digital therapeutic updates regarding FDA approvals, recent and upcoming clinical trials, and current industry regulations.
Yvette Terrie shares digital...
07/28/2023
First Report Managed Care

May 2018 Volume 15 Issue 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use